These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Insect cell technology is a versatile and robust vaccine manufacturing platform. Mena JA; Kamen AA Expert Rev Vaccines; 2011 Jul; 10(7):1063-81. PubMed ID: 21806400 [TBL] [Abstract][Full Text] [Related]
25. Polydnavirus genes that enhance the baculovirus expression vector system. Fath-Goodin A; Kroemer J; Martin S; Reeves K; Webb BA Adv Virus Res; 2006; 68():75-90. PubMed ID: 16997009 [TBL] [Abstract][Full Text] [Related]
26. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase. Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677 [TBL] [Abstract][Full Text] [Related]
27. HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Kapteyn JC; Porre AM; de Rond EJ; Hessels WB; Tijms MA; Kessen H; Slotboom AM; Oerlemans MA; Smit D; van der Linden J; Schoen P; Thus JL Vaccine; 2009 Feb; 27(9):1468-77. PubMed ID: 19110022 [TBL] [Abstract][Full Text] [Related]
28. DNA vaccination with a single-plasmid construct coding for viruslike particles protects mice against infection with a highly pathogenic avian influenza A virus. Szécsi J; Gabriel G; Edfeldt G; Michelet M; Klenk HD; Cosset FL J Infect Dis; 2009 Jul; 200(2):181-90. PubMed ID: 19505256 [TBL] [Abstract][Full Text] [Related]
29. Comparing the antibody responses against recombinant hemagglutinin proteins of avian influenza A (H5N1) virus expressed in insect cells and bacteria. Shen S; Mahadevappa G; Oh HL; Wee BY; Choi YW; Hwang LA; Lim SG; Hong W; Lal SK; Tan YJ J Med Virol; 2008 Nov; 80(11):1972-83. PubMed ID: 18814259 [TBL] [Abstract][Full Text] [Related]
30. Glycan analysis in cell culture-based influenza vaccine production: influence of host cell line and virus strain on the glycosylation pattern of viral hemagglutinin. Schwarzer J; Rapp E; Hennig R; Genzel Y; Jordan I; Sandig V; Reichl U Vaccine; 2009 Jul; 27(32):4325-36. PubMed ID: 19410619 [TBL] [Abstract][Full Text] [Related]
31. Inflexal V--the influenza vaccine with the lowest ovalbumin content. Kürsteiner O; Moser C; Lazar H; Durrer P Vaccine; 2006 Nov; 24(44-46):6632-5. PubMed ID: 16828206 [TBL] [Abstract][Full Text] [Related]
32. Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs. Kyriakis CS; De Vleeschauwer A; Barbé F; Bublot M; Van Reeth K Vaccine; 2009 Apr; 27(16):2258-64. PubMed ID: 19428840 [TBL] [Abstract][Full Text] [Related]
33. Large scale production and downstream processing of a recombinant porcine parvovirus vaccine. Maranga L; Rueda P; Antonis AF; Vela C; Langeveld JP; Casal JI; Carrondo MJ Appl Microbiol Biotechnol; 2002 Jun; 59(1):45-50. PubMed ID: 12073130 [TBL] [Abstract][Full Text] [Related]
34. Comparative efficacy of North American and antigenically matched reverse genetics derived H5N9 DIVA marker vaccines against highly pathogenic Asian H5N1 avian influenza viruses in chickens. Jadhao SJ; Lee CW; Sylte M; Suarez DL Vaccine; 2009 Oct; 27(44):6247-60. PubMed ID: 19686695 [TBL] [Abstract][Full Text] [Related]
36. Recombinant modified vaccinia virus Ankara expressing the hemagglutinin gene confers protection against homologous and heterologous H5N1 influenza virus infections in macaques. Kreijtz JH; Suezer Y; de Mutsert G; van den Brand JM; van Amerongen G; Schnierle BS; Kuiken T; Fouchier RA; Löwer J; Osterhaus AD; Sutter G; Rimmelzwaan GF J Infect Dis; 2009 Feb; 199(3):405-13. PubMed ID: 19061423 [TBL] [Abstract][Full Text] [Related]
37. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-Matrix that closes the immunity gap. Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ Vaccine; 2009 Sep; 27(40):5530-7. PubMed ID: 19607950 [TBL] [Abstract][Full Text] [Related]
38. Identification of HLA class II H5N1 hemagglutinin epitopes following subvirion influenza A (H5N1) vaccination. Zinckgraf JW; Sposato M; Zielinski V; Powell D; Treanor JJ; von Hofe E Vaccine; 2009 Aug; 27(39):5393-401. PubMed ID: 19596415 [TBL] [Abstract][Full Text] [Related]
39. Translational research on vaccines: influenza as an example. Belshe RB Clin Pharmacol Ther; 2007 Dec; 82(6):745-9. PubMed ID: 17971813 [TBL] [Abstract][Full Text] [Related]
40. Fundamentals of Baculovirus Expression and Applications. Kost TA; Kemp CW Adv Exp Med Biol; 2016; 896():187-97. PubMed ID: 27165326 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]